Socio-Demographic Predictors of Depression During the First COVID-19 Lockdown

Main Article Content

Robert Lubin Bruna Voldman Hallie Peller Heather Green

Abstract

Depression has been associated with poor health outcomes. This study sought to answer three research questions. Firstly, are there significant differences in the frequency of participants who screen positive for anxiety and depression in the population segregated by sociodemographic factors such as gender, age, living alone, and socioeconomic status (SES)?  Second, what sociodemographic factors were predictors of anxiety and depression symptoms?  The third research question, what extent does loneliness predict anxiety and depression symptoms when controlling for demographic measures. With regards to depression, the results of the analysis supported our hypothesis that low-income participants were more likely to screen positive for depression compared to higher income participants.

Article Details

How to Cite
LUBIN, Robert et al. Socio-Demographic Predictors of Depression During the First COVID-19 Lockdown. Medical Research Archives, [S.l.], v. 10, n. 11, nov. 2022. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3271>. Date accessed: 17 june 2024. doi: https://doi.org/10.18103/mra.v10i11.3271.
Section
Research Articles

References

1. Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013;11(1):129. doi:10.1186/1741-7015-11-129
2. Kaplan G, Glasser S, Murad H, et al. Depression among Arabs and Jews in Israel: a population-based study. Soc Psychiatry Psychiatr Epidemiol. 2010;45(10):931-939. doi:10.1007/s00127-009-0142-1
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
4. Iancu I, Horesh N, Lepkifker E, Drory Y. An epidemiological study of depressive symptomatology among Israeli adults: prevalence of depressive symptoms and demographic risk factors. Isr J Psychiatry Relat Sci. 2003;40(2):82-89.
5. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry. 1995;52(1):11-19. doi:10.1001/archpsyc.1995.03950130011002
6. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383-2390. doi:10.2337/dc08-0985
7. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306(11):1241-1249. doi:10.1001/jama.2011.1282
8. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord. 2002;72(3):227-236. doi:10.1016/s0165-0327(01)00413-x
9. Remes O, Brayne C, van der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav. 2016;6(7):e00497. doi:10.1002/brb3.497
10. Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet Lond Engl. 2013;382(9904):1575-1586. doi:10.1016/S0140-6736(13)61611-6
11. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet Lond Engl. 2021;398(10312):1700-1712. doi:10.1016/S0140-6736(21)02143-7
12. Israel Population 2022 (Demographics, Maps, Graphs). Accessed August 8, 2022. https://worldpopulationreview.com/countries/israel-population
13. Kroenke K, Spitzer RL, Williams JBW, Löwe B. An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4. Psychosomatics. 2009;50(6):613-621. doi:10.1016/S0033-3182(09)70864-3
14. Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163-171. doi:10.1016/j.jpsychores.2004.09.006
15. Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener. Med Care. 2003;41(11):1284-1292. doi:10.1097/01.MLR.0000093487.78664.3C
16. Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection. Ann Intern Med. 2007;146(5):317. doi:10.7326/0003-4819-146-5-200703060-00004
17. Löwe B, Wahl I, Rose M, et al. A 4-item measure of depression and anxiety: Validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1-2):86-95. doi:10.1016/j.jad.2009.06.019